Blood Sampling of Healthy Volunteers for Immunological Research
Condition(s) studied
Investigational drug(s) / intervention(s)
Blood sample: Blood sample
Study summary
This protocol will be used to collect crucial components of the immune system from healthy volunteers for the characterization of immune cells in fresh blood. A pipeline has been set up for comprehensive immune phenotyping of both lymphoid and myeloid cells within 24 hours after blood withdrawal.
Eligibility
Primary outcome measure(s)
- The number of immune cells, both lymphoid and myeloid, present in the blood of healthy individuals, assessed by flow cytometry, as well as cytokine expression and transcriptome profiles of these cells — assessed up to 12 months
the number of lymphoid and myeloid immune cells present in the blood of healthy individuals using flow cytometry, assessing the cytokine expression of these cells in healthy individuals using ELISA cytokine assays, and assessing gene expression of these cells using single cell transcriptomics analyses using droplet-based single cell RNA sequencing.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| NKI-AVL | Amsterdam | Netherlands | Recruiting |
More The Netherlands Cancer Institute trials in the Netherlands
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03819829 on ClinicalTrials.gov ↗ ← All trials in the Netherlands